Odisha: Dr Deepak Kumar Mishra becomes new director of Acharya Harihar PG Institute of Cancer

Published On 2023-05-19 10:15 GMT   |   Update On 2023-05-19 10:15 GMT

Cuttack: Colonel Deepak Kumar Mishra has been appointed as the new director of Acharya Harihar Post Graduate Institute of Cancer (AHPGIC), Cuttack. He is currently serving as the Head of the Department of Laboratory Haematology and the Director of the Department of Laboratory Sciences at the Tata Medical Centre, Kolkata. Previously Lalatendu Sarangi was serving as the director of AHPGIC....

Login or Register to read the full article

Cuttack: Colonel Deepak Kumar Mishra has been appointed as the new director of Acharya Harihar Post Graduate Institute of Cancer (AHPGIC), Cuttack. He is currently serving as the Head of the Department of Laboratory Haematology and the Director of the Department of Laboratory Sciences at the Tata Medical Centre, Kolkata.

Previously Lalatendu Sarangi was serving as the director of AHPGIC. Mishra will be serving as the director for three years from the date he joins the office or till he attains the age of 65 years, whichever is earlier, reports TOI

Also Read: 681 super speciality hospitals now under Biju Swasthya Kalyan Yojana in Odisha

Dr (Col) Deepak Kumar Mishra did his MD Pathology in 1990 from the Armed Forces Medical College (AFMC), Pune. He went on to do his Post Doctoral Fellowship in Hematology from the prestigious All India Institute of Medical Sciences (AIIMS), New Delhi in 1998. He was a UICC Fellow at the Kings College School of Medicine, London, UK( 2001); and at the Harvard Stem Cell Institute, Harvard Medical School, Boston, USA. He has been a visiting Fellow at the Mount Sinai School of Medicine, New York (2000), and at the MDS Centre in Stanford Univ School of Medicine, USA( 2003). He has been a visiting faculty at the University of Massachusetts School of Medicine, Worcester, MA, USA (2006) and at the Dept of Haematology, Christian Medical College & Hospital, Vellore (2003).

He served the armed forces for more than 25 years and has been an academic faculty in several prominent military academic and clinical institutions including AFMC, Pune, Armed Forces Transfusion Centre, New Delhi, and Army Hospital (Research & Referral), New Delhi; where he was responsible for setting up a state-of-the-art diagnostic haematology and stem cell laboratories. His last appointment was, as the Senior Adviser & Professor ( Pathology & Haematology ) at the Army Hospital (Research & Referral), New Delhi. His main areas of research interest are myelodysplastic syndromes (MDS), minimal residual disease in leukaemias, and stem cell research. He is the chair of the ICMR Task Force sub-committee on MDS and convener of the Indian MDS Registry. 

He is the Past - President of the Indian Society of Haematology & Blood Transfusion and the Honorary Secretary of the Indian Association of Pathologists and Microbiologists. He was the Past-Editor of the Indian Journal of Haematology & Blood Transfusion and the Past - Associate Editor of the Indian Journal of Pathology and Microbiology. He is a post-graduate / post-doctoral teacher and examiner in Pathology / Haematology at many universities/institutions in India.

A six-story new building for the institute has recently been built by the state government at a cost of Rs 38.36 crore. The new building will include a positron emission tomography-computed tomography scan machine, an intensive care unit (ICU) for comprehensive cancer care, and an in-patient department (IPD). Additionally, the number of beds has expanded from 287 to 507, with 20 of those beds being in the AHPGIC's ICU, reports the Daily. 

Also Read: AIIMS Bhubaneswar doctors perform rare throat cancer surgery on 25-year-old patient

Tags:    
Article Source : with inputs

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News